Related Experiment Videos
Severe Rh disease--poor outcome is not inevitable
American Journal of Obstetrics and Gynecology
|April 1, 1983
Summary
A refined management plan significantly improved survival rates for fetuses with severe Rh-isoimmune hemolytic disease, including those with hydrops fetalis. This approach enhances fetal assessment and intrauterine transfusion safety.
Area of Science:
- Perinatology
- Maternal-Fetal Medicine
- Neonatology
Background:
- Severe Rh-isoimmune hemolytic disease poses a significant risk to fetuses, with poor prognosis for hydropic infants.
- Current intrauterine treatments often yield only moderate success rates.
Purpose of the Study:
- To evaluate the efficacy of an innovative, refined management plan for severely Rh-isoimmunized fetuses.
- To assess improvements in fetal evaluation, intrauterine transfusion, and follow-up care.
Main Methods:
- Implementation of a refined management plan including extensive real-time ultrasonography for fetal assessment.
- Modification of the intrauterine transfusion procedure to enhance safety and efficacy.
- Integrated team approach for comprehensive fetal and neonatal care.
Main Results:
- Achieved 100% survival in nonhydropic fetuses and 75% survival in hydropic fetuses within the study cohort.
- Real-time ultrasonography improved disease staging, transfusion safety, and treatment response monitoring.
- The modified transfusion technique resulted in no traumatic fetal deaths and no neonatal deaths, leading to a 92% overall survival rate for transfused fetuses.
Conclusions:
- The refined management plan offers a more optimistic outlook for fetuses with severe Rh disease.
- Innovations in fetal assessment and intrauterine transfusion significantly improve survival outcomes.
- An integrated team approach is crucial for managing severe Rh-isoimmune hemolytic disease.